We are developing cancer treatments that specifically target the cancer stem cell population in tumors. Targeting these cells will prevent relapse and disease progression leading to long-term patient benefit. Meet with us: investormeeting@tnatherapeutics.com
Company Details
- Employees
- 6
- Founded
- -
- Address
- 71-75 Shelton Street,
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.TNATherapeutics.com
- Keywords
- Clinical Development, Cancer, TNBC, CRC, Oncology, Drug Development, Cell Death, Migration, Cancer Stem Cell Viability, Tumor Growth, Inflammation, BCL-3, BCL3 expression.
- HQ
- London, England
Tna Therapeutics Questions
Tna Therapeutics's website is http://www.TNATherapeutics.com
Tna Therapeutics's LinkedIn profile is https://www.linkedin.com/company/tnatherapeutics
Tna Therapeutics has
6 employees.
View email and phone details for 6
employees at Tna Therapeutics.
Tna Therapeutics's industry is
Pharmaceutical Manufacturing
Tna Therapeutics's top competitors are
Akari Therapeutics, Plc,
Adaptive Research Inc,
Aethon Therapeutics,
Mission Therapeutics,
Concarlo Therapeutics,
Cabaletta Bio,
Autolus Therapeutics,
Oviva Therapeutics,
Loqus23 Therapeutics Ltd,
Myricx Bio.
Tna Therapeutics's categories are Pharmaceutical Manufacturing
Tna Therapeutics's founding year is 2021
